In quest to leapfrog Pfizer, Peninsula vaccine company gets $85 million injection
June 07, 2018 at 17:07 PM EDT
The company is pushing into clinical trials for its experimental broad-spectrum vaccine against a bacterium that causes pneumonia and bloodstream infections.
